Interleukin-10 family cytokines pathway: genetic variants and psoriasis.
BACKGROUND
Interleukin (IL)-10 family cytokines IL-10, IL-19, IL-20 and IL-24 have been implicated in autoimmune diseases and we have previously reported that genetic variants in the IL10 gene cluster were associated with psoriasis.


OBJECTIVE
To analyse the relationship between genetic polymorphisms in the IL10 gene cluster and psoriasis. This study also explores whether there are gene-gene interactions among these genetic polymorphisms.


METHODS
A total of 377 patients with psoriasis and 403 matched healthy controls were enrolled to carry out a case-control study for 48 single-nucleotide polymorphisms (SNPs) of the IL10 gene cluster. Genotyping for the SNPs was conducted on the Applied Biosystems 3730 DNA Analyzer using SNPlex®technology. Generalized multifactor dimensionality reduction (GMDR) analysis was applied to discover a likely gene-gene interaction model among the SNPs.


RESULTS
The results showed that the allele distributions of IL10 gene cluster SNPs are significantly different between the case and control groups. Carriers of the IL10 T allele (rs1554286) and the IL20 T allele (rs1400986) conferred protection from psoriasis [odds ratio (OR) = 0·63, corrected P-value (Pc) = 0·007; OR = 0·62, Pc = 0·038, respectively]. GMDR analysis displayed a significant gene-gene interaction between IL10 (rs1554286) and IL20 (rs1518108) variants. The strongest protective effect was found with the block 1 haplotype ACATA in the IL10 gene (Pc = 0·004).


CONCLUSIONS
This study presents a novel finding that the combination of the two SNPs, IL10 (rs1554286) and IL20 (rs1518108), is associated with a reduced risk of psoriasis. Our results indicate that genetic variants of the immunomodulatory IL10 and IL20 genes may offer a protective effect in Europeans from Russia. Independent studies are required to verify the results and find a possible functional explanation.
Department of Physiology, University of Tartu, Tartu, Estonia.|Institute of Biochemistry and Genetics, Ufa Scientific Center of Russian Academy of Sciences, Ufa, Russia.
E
E
Galimova
Department of Physiology, University of Tartu, Tartu, Estonia.
R
R
Rätsep
Department of Dermatology, University of Tartu, Tartu, Estonia.
T
T
Traks
Department of Dermatology, University of Tartu, Tartu, Estonia.
K
K
Kingo
MRC Centre for Neuropsychiatric Genetics & Genomics, Cardiff University, Cardiff, U.K.
V
V
Escott-Price
Department of Physiology, University of Tartu, Tartu, Estonia.|Department of Pathophysiology, University of Tartu, Tartu, Estonia.
S
S
Kõks
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D016022:Case-Control Studies; D002648:Child; D004843:Epistasis, Genetic / Q000235:genetics; D005260:Female; D020022:Genetic Predisposition to Disease / Q000208:ethnology / Q000235:genetics; D014644:Genetic Variation; D006579:Heterozygote; D006801:Humans; D016753:Interleukin-10 / Q000235:genetics* / Q000378:metabolism; D007378:Interleukins / Q000235:genetics* / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D020641:Polymorphism, Single Nucleotide; D011565:Psoriasis / Q000235:genetics*; D012426:Russia / Q000208:ethnology; D044465:White People / Q000208:ethnology / Q000235:genetics*; D055815:Young Adult; D000099180:Interleukin-24
D016753:Interleukin-10; D007378:Interleukins; D000099180:Interleukin-24; C508609:IL10 protein, human; C421250:IL19 protein, human; C422042:interleukin 20